@article {10.3844/ajbbsp.2012.71.80,
article_type = {journal},
title = {Role of Progranulin Gene Expression as a Molecular Biomarker for Bladder Cancer},
author = {El-khair, Salwa M. Abo and Mohamed, Mie A. and Alkhiary, Tamer E.},
volume = {8},
number = {2},
year = {2012},
month = {Jun},
pages = {71-80},
doi = {10.3844/ajbbsp.2012.71.80},
url = {https://thescipub.com/abstract/ajbbsp.2012.71.80},
abstract = {Bladder cancer is the second most common cancer of the urinary system. Early diagnosis of this tumor and estimation of risk of future progression has a significant impact on prognosis. Although there are several molecular markers for the diagnosis and prognosis for this tumor, their accuracy is not ideal. Progranulin is a growth factor that may play a critical role in bladder cancer. Previous reports have shown that progranulin is essential for cellular proliferation. In this study, we examined whether progranulin gene expression can be a novel molecular marker for bladder cancer and evaluated its potential suitability as a urinary biomarker for bladder cancer diagnosis. Expression of progranulin gene in tissue and urine sediment of normal and bladder cancer samples was performed by semi-quantitative reverse transcription-PCR. Also, progranulin level was estimated in 90 voided urine samples, including 65 bladder cancer patients and 25 healthy volunteers using the quantitative enzyme immunoassay technique. Significant over-expression of progranulin was observed in bladder cancer cases. This over-expression was correlated with the stage and grade of the cancer. The urinary progranulin level was significantly higher in bladder cancer patients compared to control subjects (means: 18.39±0.56 and 9.17±0.41 ng mL-1, respectively; p},
journal = {American Journal of Biochemistry and Biotechnology},
publisher = {Science Publications}
}